GlassScriptPhysician profile
Rajesh Kumar Dubey
NPI 1225011299
$9,984.50
in general payments reported to CMS, 2019-2025
11 companies · $5,921 in 2025
The $5,921 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.59 · 2021: $67.20 · 2022: $3,764 · 2023: $147 · 2024: $7.01 · 2025: $5,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,783 · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,783.33 |
| Food and Beverage | $291.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $9,450.00 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $151.08 | 2021-2023 | Harmony |
| Abbott Laboratories | $122.38 | 2021-2025 | Gallant, Assurity, Aveir |
| Biotronik INC. | $73.45 | 2022-2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $66.72 | 2019-2022 | |
| Boston Scientific Corporation | $42.85 | 2022-2023 | Lux-Dx Insertable Cardiac Monitor |
| Edwards Lifesciences Corporation | $20.27 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2019 | |
| Sanofi Pasteur INC. | $15.28 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.76 | 2023-2024 | Lifevest |
| Gilead Sciences, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Dubey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.